The iShares U.S. Pharmaceuticals ETF is rallying along with Eli Lilly, its top holding.

Some investors are wondering when to sell Series I bonds amid falling inflation. Here’s how to maximize interest, according to experts.

These are the stocks posting the largest moves in midday trading.

Illumina’s acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union.

Nine states have passed laws addressing organized retail crime and Congress is considering federal action. Experts say the new laws may not reduce crime.

The Ark 21Shares fund is seen as the first in line for a potential bitcoin ETF launch, though the SEC could choose to approve many funds at about the same time.

The judge partially sided with Trump’s lawyers, who challenged a broader proposed ban on which evidence could be disclosed.

Art Cashin is warning investors to keep a close eye on these levels as markets approach a “critical time.”

Analyst Jason Zemansky thinks Kura Oncology could be a winner in blood cancer treatment, believing the stock could nearly triple in value.

The Investing Club holds its “Morning Meeting” every weekday at 10:20 a.m. ET.